Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903)

NCT04138212 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

456

Enrollment

OTHER_GOV

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Paclitaxel, Cisplatin
RADIATION: neoadjuvant chemoradiation therapy

Sponsor

Henan Cancer Hospital